Table 4.
Univariate and Multivariate Analysis (Cox Regression) Between OS and Clinical Characteristics in OC Patients
| Characteristics | Total (N) | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|---|
| Hazard Ratio (95% CI) | P value | Hazard Ratio (95% CI) | P value | ||
| FIGO stage (Stage III & Stage IV vs Stage I & Stage II) | 374 | 2.115 (0.938–4.766) | 0.071 | 2.868 (0.694–11.842) | 0.145 |
| Primary therapy outcome (CR vs PD&SD&PR) | 307 | 0.229 (0.166–0.318) | <0.001 | 0.245 (0.170–0.354) | <0.001 |
| Race (White vs Asian & Black or African American) | 364 | 0.637 (0.405–1.004) | 0.052 | 1.107 (0.614–1.993) | 0.736 |
| Age (>60 vs ≤60) | 377 | 1.355 (1.046–1.754) | 0.021 | 1.498 (1.082–2.073) | 0.015 |
| Histologic grade (G3&G4 vs G1&G2) | 367 | 1.229 (0.830–1.818) | 0.303 | ||
| Anatomic neoplasm subdivision (Bilateral vs Unilateral) | 356 | 1.049 (0.776–1.418) | 0.757 | ||
| Venous invasion (Yes vs No) | 105 | 0.896 (0.487–1.649) | 0.723 | ||
| Lymphatic invasion (Yes vs No) | 148 | 1.413 (0.833–2.396) | 0.200 | ||
| Tumor residual (RD vs NRD) | 334 | 2.313 (1.486–3.599) | <0.001 | 1.685 (0.990–2.869) | 0.054 |
| ELF3 (High vs Low) | 377 | 1.368 (1.054–1.775) | 0.019 | 1.779 (1.281–2.472) | <0.001 |